Fee Bengsch
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Protease and Inhibitor Mechanisms 3
- Oncology 5
- Cancer Cells and Metastasis 2
- Pancreatic and Hepatic Oncology Research 2
- CAR-T cell therapy research 1
- Co-authors
- Gregory Lawrence Beatty (2 shared papers)Hengrui Zhu (2 shared papers)Rugang Zhang (2 shared papers)Chad A. Komar (1 shared paper)Jae Woo Lee (1 shared paper)Kathleen L. Graham (1 shared paper)Michael J. Allegrezza (1 shared paper)Jose Ramon Conejo-Garcia (1 shared paper)
- Journals
- Experimental Eye Research (1 paper)Oncotarget (1 paper)Cell Cycle (1 paper)Molecular & Cellular Proteomics (1 paper)Cancer Immunology Immunotherapy (1 paper)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Fee Bengsch
9 papers receiving 812 citations
Peers
Comparison fields: 5 of 76
- Oncology 409
- Immunology 252
- Cancer Research 123
- Molecular Biology 369
- Biotechnology 41
Countries citing papers authored by Fee Bengsch
This map shows the geographic impact of Fee Bengsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fee Bengsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fee Bengsch more than expected).
Fields of papers citing papers by Fee Bengsch
This network shows the impact of papers produced by Fee Bengsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fee Bengsch. The network helps show where Fee Bengsch may publish in the future.
Co-authors
The 25 scholars most cited alongside Fee Bengsch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 375 | |
| 2 | 2016 | 175 | |
| 3 | 2017 | 94 | |
| 4 | 2013 | 89 | |
| 5 | 2012 | 37 | |
| 6 | 2015 | 22 | |
| 7 | 2013 | 17 | |
| 8 | 2016 | 8 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 0 |
About Fee Bengsch
Fee Bengsch is a scholar working on Cancer Research, Oncology, Immunology and Allergy, Microbiology and Ophthalmology, having authored 10 papers that have together received 819 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (3 papers), Cell Adhesion Molecules Research (2 papers), Cancer Cells and Metastasis (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Ubiquitin and proteasome pathways (2 papers), Immune Cell Function and Interaction (1 paper), Cancer Research and Treatments (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (409 citations), Immunology (252 citations), Cancer Research (123 citations), Molecular Biology (369 citations) and Biotechnology (41 citations). Fee Bengsch has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Gregory Lawrence Beatty, Hengrui Zhu, Rugang Zhang, Chad A. Komar, Jae Woo Lee, Kathleen L. Graham, Michael J. Allegrezza, Jose Ramon Conejo-Garcia, Benjamin G. Bitler and James E. Bradner. Their work appears in journals such as Experimental Eye Research, Oncotarget, Cell Cycle, Molecular & Cellular Proteomics and Cancer Immunology Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.